NFKB1 and pulmonary fibrosis: Additionally, the small molecule inhibitor J2 of heat shock protein-27 (HSP-27), a candidate target used in mouse models for the treatment of pulmonary fibrosis (Table 1), inhibits the development of RIPF by inhibiting IkBa-NFkB signaling after cross-linking HSP27 [104].